---
figid: PMC2889129__nihms185597f8a
figlink: /pmc/articles/PMC149053/figure/fig7/
number: F8a
caption: Proposed model for the role of Twist1 in the ovarian cancer stem cells. (a)
  In the ovarian cancer stem cells, undetectable levels of Twist1 results in undetectable
  expression of hsa-miR-199a and hsa-miR-214, the inhibitors of IKKβ and PTEN, respectively.
  This leads to high expression of both IKKβ and PTEN. As a result, the ovarian cancer
  stem cells have constitutive NF-kB activity, which creates a pro-inflammatory and
  anti-apoptotic environment, and an inactive Akt pathway, leading to slow proliferation.
  (b) In the mature ovarian cancer cells, high levels of Twist1 leads to the expression
  of hsa-miR-199a and hsa-miR-214, which downregulates IKKβ and PTEN, respectively.
  As a result, mature/differentiated ovarian cancer cells do not have a constitutive
  NF-kB pathway, but instead have a highly active Akt pathway. These cells do not
  have a pro-inflammatory environment, are chemosensitive, and proliferate faster.
pmcid: PMC2889129
papertitle: TWISTing Stemness, Inflammation, and Proliferation of Epithelial Ovarian
  Cancer Cells through MIR199A2/214.
reftext: Gang Yin, et al. Oncogene. 2010 Jun 17;29(24):3545-3553.
pmc_ranked_result_index: '32753'
pathway_score: 0.9440444
filename: nihms185597f8a.jpg
figtitle: TWISTing Stemness, Inflammation, and Proliferation of Epithelial Ovarian
  Cancer Cells through MIR199A2/214
year: '2010'
organisms:
- Homo sapiens
ndex: ed61b3be-deed-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2889129__nihms185597f8a.html
  '@type': Dataset
  description: Proposed model for the role of Twist1 in the ovarian cancer stem cells.
    (a) In the ovarian cancer stem cells, undetectable levels of Twist1 results in
    undetectable expression of hsa-miR-199a and hsa-miR-214, the inhibitors of IKKβ
    and PTEN, respectively. This leads to high expression of both IKKβ and PTEN. As
    a result, the ovarian cancer stem cells have constitutive NF-kB activity, which
    creates a pro-inflammatory and anti-apoptotic environment, and an inactive Akt
    pathway, leading to slow proliferation. (b) In the mature ovarian cancer cells,
    high levels of Twist1 leads to the expression of hsa-miR-199a and hsa-miR-214,
    which downregulates IKKβ and PTEN, respectively. As a result, mature/differentiated
    ovarian cancer cells do not have a constitutive NF-kB pathway, but instead have
    a highly active Akt pathway. These cells do not have a pro-inflammatory environment,
    are chemosensitive, and proliferate faster.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3R5
  - PIK3R6
  - PIK3R4
  - TLR8
  - TNFRSF1A
  - AKT3
  - PIK3CB
  - TLR7
  - THRB
  - IL1R1
  - IKBKG
  - AKT1
  - PIK3CD
  - TLR10
  - TLR5
  - NFKB1
  - PIK3R3
  - TLR4
  - TLR6
  - AKT2
  - TLR9
  - PIK3CG
  - TLR2
  - CHUK
  - THRA
  - TLR1
  - TLR3
  - PTEN
  - Ser
  - Thr
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: /TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: Thr
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRB
  entrez: '7068'
- word: TLR/IL1-R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: (IKKY
  symbol: IKK-gamma
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: IKKa
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: Thr
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRA
  entrez: '7067'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR/IL1-R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
chemicals:
- word: Ser
  source: MESH
  identifier: D012694
- word: Thr
  source: MESH
  identifier: D013912
diseases: []
figid_alias: PMC2889129__F8a
redirect_from: /figures/PMC2889129__F8a
figtype: Figure
---
